XBiotech Inc. — Director's Dealing 2019

Dec 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-11-29

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-29	Common Stock	M	185000	$3.75	Acquired	3583600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-29	Stock Option	$3.75	M	185000	Disposed	2019-11-30	Common Stock (185000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	47738	Indirect
Common Stock	11501	Indirect
Common Stock	100000	Indirect